BioRem
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioRem generated cash of $490,033, which is less than the previous year. Cash used in financing activities reached the amount of -$1,329,231 last year. Net change in cash is therefore -$1,483,219.
Cash Flow
| 2014 | -445.59K | -37.69K | -218.83K |
|---|---|---|---|
| 2015 | 2.14M | 96 | -787.61K |
| 2016 | -777.77K | -11.96K | -924.01K |
| 2017 | 1.17M | -14.33K | 685.67K |
| 2018 | -2.52K | -230.71K | 0 |
| 2019 | 2.52M | -135.23K | -109.36K |
| 2020 | 3.33M | -342.4K | -199.74K |
| 2021 | 3.78M | -75.97K | -7.55M |
| 2022 | 1.44M | -203.28K | -951.79K |
| 2023 | 490.03K | -552.87K | -1.32M |
BRM.V Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.77M | 4.47M | 8.86M | 6.46M | 3.95M | 3.56M | 1.11M | 2.72M | 1.21M | 1.64M |
Operating activities | ||||||||||
Net income | 2.17M | 1.61M | 1.29M | 2.08M | -1.30M | 4.66M | 1.53M | 547.27K | 1.68M | -1.72M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 382.70K | 350.64K | 343.62K | 354.46K | 208.52K | 50.69K | 35.23K | 50.96K | 121.60K | 360.14K |
Stock-based compensation expense | 127.65K | 93.69K | 8.43K | 20.29K | 109.91K | 0 | 102.55K | 4.06K | 3.2K | 3.6K |
| Deferred income tax benefit | 127.65K | 93.69K | 8.43K | 20.29K | 109.91K | 0 | 102.55K | 4.06K | 3.2K | 3.6K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3.03M | -1.32M | -185.62K | -2.63M | 4.30M | -115.17K | -1.01M | -4.47M | 314.67K | 693.98K |
Inventories | -39.02K | 245.49K | 43.11K | 196.77K | -867.72K | 303.97K | -310.23K | 233.08K | -139.17K | -58.89K |
Accounts payable | 1.38M | 743.5K | 3.25M | -26.09K | -1.40M | -398.24K | 1.18M | 1.19M | 158.57K | -811.66K |
Cash generated by operating activities | 490.03K | 1.44M | 3.78M | 3.33M | 2.52M | -2.52K | 1.17M | -777.77K | 2.14M | -445.59K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -552.87K | -203.28K | -75.97K | -342.4K | -135.23K | -230.71K | -14.33K | -11.96K | -6.46K | -29.80K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.56K | 0 |
Cash generated by investing activities | -552.87K | -203.28K | -75.97K | -342.4K | -135.23K | -230.71K | -14.33K | -11.96K | 96 | -37.69K |
Financing activities | ||||||||||
Common Stock Issued | 69K | 2K | 5.09M | 0 | 0 | 0 | 726.73K | 24.49K | 163.81K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -12.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.30M | -733.81K | -239.12K | -199.74K | -109.36K | 0 | 0 | -895K | -770K | 0 |
Cash used in financing activities | -1.32M | -951.79K | -7.55M | -199.74K | -109.36K | 0 | 685.67K | -924.01K | -787.61K | -218.83K |
Net Change In Cash | -1.48M | -696.28K | -4.39M | 2.40M | 2.51M | 381.94K | 2.45M | -1.60M | 1.51M | -428.23K |
Cash at end of period | 2.29M | 3.77M | 4.47M | 8.86M | 6.46M | 3.95M | 3.56M | 1.11M | 2.72M | 1.21M |